Camp4 Therapeutics Corporation (CAMP)
NASDAQ: CAMP · Real-Time Price · USD
3.850
-0.540 (-12.30%)
At close: Feb 13, 2026, 4:00 PM EST
3.780
-0.070 (-1.82%)
After-hours: Feb 13, 2026, 4:10 PM EST
Camp4 Therapeutics Employees
Camp4 Therapeutics had 55 employees as of December 31, 2024. The number of employees decreased by 9 or -14.06% compared to the previous year.
Employees
55
Change
-9
Growth
-14.06%
Revenue / Employee
$69,127
Profits / Employee
-$970,873
Market Cap
199.74M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 55 | -9 | -14.06% |
| Sep 30, 2024 | 53 | -11 | -17.19% |
| Jun 30, 2024 | 58 | - | - |
| Dec 31, 2023 | 64 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Arcturus Therapeutics Holdings | 176 |
| Alector | 156 |
| Heron Therapeutics | 122 |
| Silence Therapeutics | 116 |
| MediWound | 111 |
| Orchestra BioMed Holdings | 70 |
| Surrozen | 41 |
| Achieve Life Sciences | 25 |
CAMP News
- 4 weeks ago - CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 4 weeks ago - Camp4 Therapeutics Corporation (CAMP) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 5 weeks ago - CAMP4 to Present at the 44th Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 2 months ago - CAMP4 Announces Pricing of $30.0 Million Underwritten Offering of Common Stock - GlobeNewsWire
- 2 months ago - CAMP4 and GSK Enter Strategic Collaboration to Advance RNA-Based Therapeutic Discoveries - GlobeNewsWire
- 2 months ago - CAMP4 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 3 months ago - CAMP4 Reports Third Quarter 2025 Financial Results and Corporate Highlights - GlobeNewsWire
- 4 months ago - CAMP4 Therapeutics Initiates GLP Toxicology Studies for CMP-SYNGAP-01 - GlobeNewsWire